Study on formability of solid nanosuspensions during nanodispersion and solidification: I. Novel role of stabilizer/drug property

International Journal of Pharmaceutics

Volumn 454, Issue 1, 2013, Pages 269-277

  Yue, Peng Fei ^a,b   Li, Yu ^a   Wan, Jing ^a   Yang, Ming ^a   Zhu, Wei Feng ^a   Wang, Chang Hong ^b  

^a JIANGXI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cohesive energy; Contact angle; Formability; Nanodispersion; Redispersibility; Solid nanosuspension; Solidification

Indexed keywords

BAICALIN; HYDROXYPROPYLMETHYLCELLULOSE; NARINGENIN; OLEANOLIC ACID; POVIDONE; PUERARIN; RESVERATROL; STABILIZING AGENT; SURFACTANT; URSODEOXYCHOLIC ACID;

ARTICLE; COMPARATIVE STUDY; CONTACT ANGLE; DISPERSION; FREEZE DRYING; FREEZING; HYDROPHOBICITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SOLID; SURFACE TENSION; WETTABILITY;

EID: 84884144445     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.06.050     Document Type: Article

References (25)

1. Abdelwahed, W., Degobert, G., Stainmesse, S., Fessi, H., 2006. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv. Drug Deliv. Rev. 58, 1688-1713. (Pubitemid 44827432)
2. Beirowski, J., Inghelbrecht, S., Arien, A., Gieseler, H., 2011a. Freeze drying of nanosuspensions: 1. Freezing rate versus formulation design as critical factors to preserve the original particle size distribution. J. Pharm. Sci. 100, 1958-1968.
3. Beirowski, J., Inghelbrecht, S., Arien, A., Gieseler, H., 2009. Investigation of various Poloxamers as freeze-drying stabilizers in freeze-drying of nanosuspensions. In: Proc. Parent Drug Association, Frankfurt/Main, Germany.
4. Beirowski, J., Inghelbrecht, S., Arien, A., van Assche, I., Gieseler, H., 2010a. Stabilization of nanosuspensions during freeze-drying: The role of vitrification (Part 1). In: Proceedings of the Seventh World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Valetta, Malta, March 8-11.
5. Beirowski, J., Inghelbrecht, S., Arien, A., van Assche, I., Gieseler, H., 2010b. Stabilization of nanosuspensions during freeze-drying: the role of vitrification and its practical implications (Part 2). In: Proceedings of the Seventh World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology, Valetta, Malta, March 8-11.
6. Beirowski, J., Inghelbrecht, S., Arien, A., Gieseler, H., 2011b. Freeze-drying of nanosuspensions: 2. The role of the critical formulation temperature on stability of drug-nanosuspensions and its practical implication on process design. J. Pharm. Sci. 100, 4471-4481.
7. Chiang, P.C., Wahlstrom, J.L., Selbo, J.G., Zhou, S., Wene, S.P., Albin, L.A., Warren, C.J., Smith, M.E., Roberds, S.L., Ghosh, S., Zhang, L.L., Pretzer, D.K., 2007. 1,3-Dicyclohexylurea nanosuspension for intraveneous steady-state delivery in rats. J. Exp. Nanosci. 2, 239-250. (Pubitemid 47342895)
8. Gao, L., Zhang, D., Chen, M., 2008. Drug nanocrystals for the formulation of poorly soluble drugs and its application as a potential drug delivery system. J. Nanopart. Res. 10, 845-862.
9. Kesisoglou, F., Panmai, S., Wu, Y., 2007. Nanosizing: oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 59, 631-644. (Pubitemid 47285408)
10. Kumar, M.P., Rao, Y.M., Apte, S., 2007. Improved bioavailability of albendazole following oral administration of nanosuspension in rats. Curr. Nanosci. 3, 191-194. (Pubitemid 46845726)
11. Kumar, M.P., Rao, Y.M., Apte, S., 2008. Formulations of nanosuspensions of albendazole for oral administration. Curr. Nanosci. 4, 53-58. (Pubitemid 351513461)
12. Merisko-Liversidge, E., Liversidge, G.G., Cooper, E.R., 2003. Nanosizing: a formulation approach for poorly water-soluble compounds. Eur. J. Pharm. Sci. 18, 113-120. (Pubitemid 36184748)
13. Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J.M., Pugh, S., Polin, L., Jones, J., Corbett, T., Cooper, E., Liversidge, G.G., 1996. Formulation and antitumoractivity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs. Pharm. Res. 13, 272-278.
14. Mouton, J.W., van Peer, A., de Beule, K., van Vliet, A., Donnelly, J.P., Soons, P.A., 2006. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation. Antimicrob. Agents Chemother. 50, 4096-4102.
15. Müller, R.H., Möschwitzer, J., Bushrab, F.N., 2006. Manufacturing of nanoparticles by milling and homogenization techniques. In: Gupta, R.B., Kompella, U.B. (Eds.), Nanoparticle Technology for Drug Delivery, Drugs and the Pharmaceutical Sciences, vol. 159. Taylor & Francis Group, LLC, NY, USA, pp. 21-51.
16. Patravale, V.B., Date, A.A., Kulkarni, R.M., 2004. Nanosuspensions a promising drug delivery strategy. J. Pharm. Pharmacol. 56, 827-840. (Pubitemid 38885975)
17. Rabinow, B.E., 2004. Nanosuspensions in drug delivery. Nat. Rev. 3, 785-796. (Pubitemid 39242830)
18. Van Eerdenbrugh, B., Van den Mooter, G., Augustijns, P., 2008a. Top-down production of drug nanocrystals nanosuspension stabilization, miniaturization and transformation into solid products. Int. J. Pharm. 364, 64-75.
19. Van Eerdenbrugh, B., Vercruysse, S., Martens Johan, A., Vermant, J., Froyen, L., Van Humbeeck, J., Van den Mooter, G., Augustijns, P., 2008b. Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions: a case study with itraconazole. Eur. J. Pharm. Biopharm. 70, 590-596.
20. Van Eerdenbrugh, B., Vermant, J., Martens, J.A., Froyen, L., Van Humbeeck, J., Augustijns, P., Van den Mooter, G., 2009. A screening study of surface stabilization during the production of drug nanocrystals. J. Pharm. Sci. 98, 2091-2103.
21. Wong, J., Brugger, A., Khare, A., Chaubal, M., Papadopoulos, P., Rabinow, B., Kipp, J., Ning, J., 2008. Suspensions for intravenous (IV) injection: a review of development, clinical and preclinical aspects. Adv. Drug Deliv. Rev. 60, 939-954.
22. Wahlstrom, J.L., Chiang, P.C., Ghosh, S., Warren, C.J., Wene, S.P., Albin, L.A., Smith, M.E., Roberds, S.L., 2007. Pharmacokinetic evaluation of a 1,3-dicyclohexylurea nanosuspension formulation to support early efficacy assessment. Nanoscale Res. Lett. 2, 291-296. (Pubitemid 47139334)
23. Wang, B.H., Zhang, W.B., Zhang, W., 2005. Progress in drying technology for nanomaterials. Dry. Technol. 23, 7-32. (Pubitemid 40390262)
24. Yue, P.F., Wan, J., Hu, P.Y., Wu, Z.F., Yang, M., 2012a. Progress and thoughts on solidification nanosuspensions drug delivery system of traditional Chinese medicine. Chinese Tradit. Herb. Drugs 43, 625-629.
25. Yue, P.F., Wang, Y., Wan, J., Wu, Z.F., Hu, P.Y., Zheng, Q., Yuan, H.L., Yang, M., 2012b. The research process of solid nanocrystal delivery system on preparation methods. Acta Pharm. Sin. 47, 1120-1127.